SZD:FRA
Santen Pharmaceutical Co Ltd
8,40 €
arrow_downward
−2,33%(−0,20) 1 p
30. apr, 22:00:00 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SZD põhistatistika genereerimine…
Ava
8,40 €
Kõrge
8,40 €
Madal
8,40 €
Turu kapit.
529,51Â mld
Keskm. maht
2,00
Maht
0,00
52 näd kõrgeim
10,20 €
52 näd madalaim
8,05 €
Töötajate arv
4Â tuh
Uudised
Erinevatest veebiallikatest
富途牛牛
·
38 minuti eest
The S&P keeps hitting new highs, but smart money is retreating. Goldman Sachs' trading desk warns: a flash crash is only a matter of time.
Simply Wall Street
·
39 minuti eest
BioNTech (BNTX) Is Down 7.5% After Tariff Jitters, Leadership Shifts And Cut Guidance Reset — Has The Bull Case Changed?
Investor's Business Daily
·
45 minuti eest
Futures Mixed; U.S. To 'Guide' Ships Through Hormuz
Gotrade
·
51 minuti eest
S&P 500 and Nasdaq Hit Records, US Futures Steady
Profiil
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Teave üksuse Santen Pharmaceutical Co Ltd kohta
TegevjuhtAkira Kurokawa | Shigeo Taniuchi
Töötajad3,85 tuh
Asutatud1890
PeakontoridÅŒsaka, Kansai, Jaapan
Sektor-
Veebisaitsanten.com
AI genereeritud sisu võib sisaldada vigu. Lisateave